Status:
TERMINATED
Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Bronchiectasis Adult
Mediastinal Lymphadenopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of a...
Eligibility Criteria
Inclusion
- Diagnosis of mediastinal and/or hilar lymphadenopathy requiring endobronchial ultrasound evaluation and transbronchial needle aspiration.
- Diagnosis of pulmonary disease requiring flexible bronchoscopy
- Greater than 18 years of age.
Exclusion
- Any intervention beyond flexible bronchoscopy and endobronchial ultrasound
- Inability to tolerate bronchoscopy.
- Patients that receive paralytics.
- Patients with neuromuscular diseases.
- Inability to consent for procedures.
- Allergies to lidocaine or any other drugs used in protocol.
- Existing renal insufficiency or liver disease
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03829618
Start Date
April 1 2019
End Date
August 31 2020
Last Update
October 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States, 17036